Loading...
XKRX
28513K
Market cap787mUSD
Jun 10, Last price  
26,800.00KRW
1D
0.97%
1Q
29.68%
IPO
-11.86%
Name

SK Chemicals Co Ltd

Chart & Performance

D1W1MN
No data to show
P/E
124.12
P/S
0.63
EPS
215.93
Div Yield, %
1.54%
Shrs. gr., 5y
3.67%
Rev. gr., 5y
4.00%
Revenues
1.74t
-0.69%
87,836,375,1401,367,719,213,2601,427,185,610,6501,214,709,208,8602,089,631,876,4201,829,191,322,9201,748,777,740,3801,736,778,902,010
Net income
8.84b
-77.83%
-8,535,887,3906,028,110,0505,021,553,8108,974,845,740370,609,564,720191,266,055,00039,863,822,0008,838,745,400
CFO
-89.35b
L
-10,668,500,26067,370,210,690122,134,530,440247,009,579,320509,316,464,740-186,535,765,430141,513,593,206-89,345,889,780
Dividend
Aug 08, 2024400 KRW/sh
Earnings
Aug 04, 2025

Profile

SK Chemicals Co., Ltd. provides chemicals and life sciences products and solutions in South Korea and internationally. The company develops copolysters, coating and adhesive materials, engineering plastics, prepergs, bio materials, and 3D printing materials, as well as specialty chemicals, pharmaceutical products, and vaccines. It has a collaborate agreement with Standigm, Inc. to develop an AI-driven drug candidate for non-alcoholic steatohepatitis. The company was founded in 1969 and is headquartered in Seongnam, South Korea.
IPO date
Jan 05, 2018
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
1,736,778,902
-0.69%
1,748,777,740
-4.40%
1,829,191,323
-12.46%
Cost of revenue
1,613,230,145
1,526,406,804
1,463,920,189
Unusual Expense (Income)
NOPBT
123,548,757
222,370,937
365,271,134
NOPBT Margin
7.11%
12.72%
19.97%
Operating Taxes
(23,076,339)
4,580,808
5,224,848
Tax Rate
2.06%
1.43%
NOPAT
146,625,095
217,790,129
360,046,286
Net income
8,838,745
-77.83%
39,863,822
-79.16%
191,266,055
-48.39%
Dividends
(17,638,487)
(29,881,812)
(67,232,073)
Dividend yield
3.76%
5.14%
9.24%
Proceeds from repurchase of equity
(48,237,727)
BB yield
6.63%
Debt
Debt current
438,297,051
463,790,193
551,781,861
Long-term debt
1,244,393,928
662,798,390
200,015,631
Deferred revenue
51,026,374
Other long-term liabilities
7,945,319
6,691,141
2,812,733
Net debt
1,045,099,230
(610,198,971)
297,329,108
Cash flow
Cash from operating activities
(89,345,890)
141,513,593
(186,535,765)
CAPEX
(422,095,376)
(399,901,680)
(302,728,270)
Cash from investing activities
(157,328,639)
(510,390,210)
230,967,888
Cash from financing activities
379,974,961
355,537,871
107,152,680
FCF
(943,859,194)
(152,641,451)
(138,947,529)
Balance
Cash
1,393,877,393
1,600,434,084
1,719,770,556
Long term investments
(756,285,645)
136,353,470
(1,265,302,172)
Excess cash
550,752,803
1,649,348,667
363,008,817
Stockholders' equity
1,792,096,370
1,522,374,076
1,528,214,863
Invested Capital
4,199,387,097
2,269,979,636
3,039,414,229
ROIC
4.53%
8.20%
12.64%
ROCE
2.56%
5.86%
10.74%
EV
Common stock shares outstanding
23,570
19,190
19,290
Price
19,910.00
-34.29%
30,300.00
-19.63%
37,700.00
-57.59%
Market cap
469,278,461
-19.29%
581,463,727
-20.05%
727,240,276
-58.20%
EV
2,357,227,828
578,435,610
1,597,353,463
EBITDA
259,097,607
335,256,314
456,736,230
EV/EBITDA
9.10
1.73
3.50
Interest
41,439,574
15,707,072
15,461,271
Interest/NOPBT
33.54%
7.06%
4.23%